Q32 Bio Inc. Common Stock (QTTB) is a publicly traded Healthcare sector company. As of August 25, 2026, QTTB trades at $16.61 with a market cap of $475.42M and a P/E ratio of 5.28. QTTB moved +1.34% today. Year to date, QTTB is +392.77%; over the trailing twelve months it is +756.54%. Its 52-week range spans $1.35 to $23.57. Analyst consensus is strong buy with an average price target of $42.75. Rallies surfaces QTTB's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
4 analysts cover QTTB: 0 strong buy, 4 buy, 0 hold, 0 sell, and 0 strong sell. The consensus rating is strong buy. The average price target is $42.75.
| Metric | Value |
|---|---|
| Price | $16.61 |
| Market Cap | $475.42M |
| P/E Ratio | 5.28 |
| EPS | $3.15 |
| Dividend Yield | 0.00% |
| 52-Week High | $23.57 |
| 52-Week Low | $1.35 |
| Volume | 380.08K |
| Avg Volume | 0 |
| Revenue (TTM) | $53.95M |
| Net Income | $33.79M |
| Gross Margin | 0.00% |
4 analysts cover QTTB: 0 strong buy, 4 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $42.75.